Intravitreal Aflibercept as an Adjunct to Systemic Therapy in a Case of Choroidal Neovascular Membrane Associated with Sympathetic Ophthalmia

• Main Authors: Ali Osman Saatçi, Ziya Ayhan, Şefik Can İpek, Meltem Söylev Bajin
• Format: Article
• Language: English
• Published: Galenos Yayinevi 2018-08-01
• Series: Türk Oftalmoloji Dergisi
• Subjects: Aflibercept; choroidal neovascular membrane; prednisolone; sympathetic ophthalmia
• Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/ntravitreal-aflibercept-as-an-adjunct-to-systemic-/19558

Choroidal neovascular membrane (CNV) is a very rare complication in patients with sympathetic ophthalmia. We hereby report a 38-year-old man who developed a type 2 CNV in his only seeing (left) eye while under systemic steroid treatment. Systemic therapy was revised and a total of 5 intravitreal aflibercept injections (2 mg each) were administered over a period of 8 months. Good anatomic and functional outcome was noted at the last visit. Anti-vascular endothelial growth factor injection may be an important adjunct to systemic therapy in eyes with with sympathetic ophthalmia-associated CNV.